Form 483

Spa De Soleil, Inc. Form 483, 2017-06-23

FDA issued a Form 483 to Spa De Soleil, Inc. on 2017-06-23 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Spa De Soleil, Inc. · Sun Valley, United States · Issued June 23, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Jun 2017
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Jacob W Reynolds, Daniel Velasquez

23 Jun 2017
21 CFR 211.122(a)

Written procedures describing in detail

Cited by Jacob W Reynolds, Daniel Velasquez

23 Jun 2017
21 CFR 211.130

Procedures are written, and followed

Cited by Jacob W Reynolds, Daniel Velasquez

23 Jun 2017
21 CFR 211.165(c)

Sampling and testing plans not described

Cited by Jacob W Reynolds, Daniel Velasquez

23 Jun 2017
21 CFR 211.166(a)

Lack of written stability program

Cited by Jacob W Reynolds, Daniel Velasquez

Inspected site

SDSpa De Soleil, Inc.Sun Valley, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.122(a)Cited across public-safe Form 483 observations1x
21 CFR 211.130Cited across public-safe Form 483 observations1x
21 CFR 211.165(c)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere